Starlink is actively discussing its satellite services with the Indian government. The company has received positive feedback on its potent...

Maharashtra's government has boosted the powers of district collectors and divisional commissioners. This move aims to speed up approvals f...

British pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...

A Kochi-based manager is raising concerns after their employer deducts salary for approved annual leave, a policy not disclosed during hiri...

India is welcoming top universities from the UK and Australia to set up campuses. The University of Bristol and University of York will ope...

The Centre has approved a substantial labour budget of 153 lakh person-days for West Bengal under the MGNREGS for June 2026. This initiativ...

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...

Hardwyn India has announced a 2:5 bonus issue, subject to shareholder approval at an EGM on July 3. The company also plans to increase its ...

The U.S. has approved a $1.5 billion sale of five Seahawk helicopters to New Zealand, a move supporting the nation's plan to nearly double ...

Evonith Steel has successfully acquired Indrajit Power Pvt Ltd for Rs 232 crore. This acquisition was completed through an insolvency proce...

The US Senate on Friday approved $70 billion in funding for Donald Trump's hardline immigration crackdown, handing the president a major vi...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...

Oyo, the hospitality brand, has secured approval from the Securities and Exchange Board of India for its initial public offering. The compa...

An employee requested four days of PTO to handle a family issue, and the leave was approved in writing by their manager. However, the situa...

Wockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....

Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...

Wockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...